India recorded 56,282 new COVID-19 cases on Thursday taking the total tally of the disease close to the 20 lakh figure.
As of now, the tally stands at 1,964,536. This is the eighth consecutive day that COVID-19 cases have increased by more than 50,000.
The highest number of COVID-19 cases are being reported from Maharashtra (4,68,265), Tamil Nadu (273,000), Andhra Pradesh (1,76,333), Karnataka (150,000) and Delhi (140,232).
India at present has 5,95,501 active COVID-19 cases while the fatality figure stands at 40,699.
It recorded 904 deaths in the last 24 hours.
Of the total deaths recorded in the last 24 hours, 334 are from Maharashtra, 112 from Tamil Nadu, 100 from Karnataka and 77 from Andhra Pradesh.
West Bengal recorded 61 death while 40 were from Uttar Pradesh, 29 from Punjab, 23 from Gujarat, from Madhya Pradesh and 13 each from Rajasthan and Telangana.
The country has so far tested 2.21 crore samples, of which 6,64,949 samples were tested on Wednesday.
The tests per million have increased to 15,568.
The country has a recovery rate of 67.19% an improvement from the earlier 63% while the fatality rate is at 2.09%.
The number of cured/discharged patients now exceeds the active cases by over 7 lakh.
Zydus begins second phase trial
Meanwhile, pharmaceutical company Zydus Cadila said it will begin phase two of the clinical trials of its COVID-19 vaccine.
The company earlier said ZyCoV-D was found to be safe in phase 1 of the clinical trial. It said the vaccine was found to have a high level of neutralising antibodies in animal studies.
The company received the central drugs controller’s approval for human trials on July 2.
Drugmaker Cipla said it is also working with the government to develop COVID-19 treatment medicines.
To read the latest news in Gujarati click here